These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 34431571)

  • 1. Ebola virus protein VP40 binding to Sec24c for transport to the plasma membrane.
    Bhattarai N; Pavadai E; Pokhrel R; Baral P; Hossen ML; Stahelin RV; Chapagain PP; Gerstman BS
    Proteins; 2022 Feb; 90(2):340-350. PubMed ID: 34431571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conserved proline-rich region of Ebola virus matrix protein VP40 is essential for plasma membrane targeting and virus-like particle release.
    Reynard O; Nemirov K; Page A; Mateo M; Raoul H; Weissenhorn W; Volchkov VE
    J Infect Dis; 2011 Nov; 204 Suppl 3():S884-91. PubMed ID: 21987765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ALIX Rescues Budding of a Double PTAP/PPEY L-Domain Deletion Mutant of Ebola VP40: A Role for ALIX in Ebola Virus Egress.
    Han Z; Madara JJ; Liu Y; Liu W; Ruthel G; Freedman BD; Harty RN
    J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S138-45. PubMed ID: 25786915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A cationic, C-terminal patch and structural rearrangements in Ebola virus matrix VP40 protein control its interactions with phosphatidylserine.
    Del Vecchio K; Frick CT; Gc JB; Oda SI; Gerstman BS; Saphire EO; Chapagain PP; Stahelin RV
    J Biol Chem; 2018 Mar; 293(9):3335-3349. PubMed ID: 29348171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ebola virus matrix protein VP40 uses the COPII transport system for its intracellular transport.
    Yamayoshi S; Noda T; Ebihara H; Goto H; Morikawa Y; Lukashevich IS; Neumann G; Feldmann H; Kawaoka Y
    Cell Host Microbe; 2008 Mar; 3(3):168-77. PubMed ID: 18329616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A loop region in the N-terminal domain of Ebola virus VP40 is important in viral assembly, budding, and egress.
    Adu-Gyamfi E; Soni SP; Jee CS; Digman MA; Gratton E; Stahelin RV
    Viruses; 2014 Oct; 6(10):3837-54. PubMed ID: 25330123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chaperone-Mediated Autophagy Protein BAG3 Negatively Regulates Ebola and Marburg VP40-Mediated Egress.
    Liang J; Sagum CA; Bedford MT; Sidhu SS; Sudol M; Han Z; Harty RN
    PLoS Pathog; 2017 Jan; 13(1):e1006132. PubMed ID: 28076420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrated Computational Approach for Virtual Hit Identification against Ebola Viral Proteins VP35 and VP40.
    Mirza MU; Ikram N
    Int J Mol Sci; 2016 Oct; 17(11):. PubMed ID: 27792169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of monomeric Ebola VP40 protein with a plasma membrane: A coarse-grained molecular dynamics (CGMD) simulation study.
    Mohamad Yusoff MA; Abdul Hamid AA; Mohammad Bunori N; Abd Halim KB
    J Mol Graph Model; 2018 Jun; 82():137-144. PubMed ID: 29730487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. VP40 of the Ebola Virus as a Target for EboV Therapy: Comprehensive Conformational and Inhibitor Binding Landscape from Accelerated Molecular Dynamics.
    Balmith M; Soliman ME
    Cell Biochem Biophys; 2017 Mar; 75(1):65-78. PubMed ID: 28144904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cysteine Mutations in the Ebolavirus Matrix Protein VP40 Promote Phosphatidylserine Binding by Increasing the Flexibility of a Lipid-Binding Loop.
    Johnson KA; Bhattarai N; Budicini MR; LaBonia CM; Baker SCB; Gerstman BS; Chapagain PP; Stahelin RV
    Viruses; 2021 Jul; 13(7):. PubMed ID: 34372582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elucidating Residue-Level Determinants Affecting Dimerization of Ebola Virus Matrix Protein Using High-Throughput Site Saturation Mutagenesis and Biophysical Approaches.
    Narkhede YB; Bhardwaj A; Motsa BB; Saxena R; Sharma T; Chapagain PP; Stahelin RV; Wiest O
    J Phys Chem B; 2023 Jul; 127(29):6449-6461. PubMed ID: 37458567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct Immunogenicity and Efficacy of Poxvirus-Based Vaccine Candidates against Ebola Virus Expressing GP and VP40 Proteins.
    Lázaro-Frías A; Gómez-Medina S; Sánchez-Sampedro L; Ljungberg K; Ustav M; Liljeström P; Muñoz-Fontela C; Esteban M; García-Arriaza J
    J Virol; 2018 Jun; 92(11):. PubMed ID: 29514907
    [No Abstract]   [Full Text] [Related]  

  • 14. Ebola Virus VP40 Modulates Cell Cycle and Biogenesis of Extracellular Vesicles.
    Pleet ML; Erickson J; DeMarino C; Barclay RA; Cowen M; Lepene B; Liang J; Kuhn JH; Prugar L; Stonier SW; Dye JM; Zhou W; Liotta LA; Aman MJ; Kashanchi F
    J Infect Dis; 2018 Nov; 218(suppl_5):S365-S387. PubMed ID: 30169850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-active site mutations disturb the loop dynamics, dimerization, viral budding and egress of VP40 of the Ebola virus.
    Balmith M; Soliman ME
    Mol Biosyst; 2017 Feb; 13(3):585-597. PubMed ID: 28170013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutation of Hydrophobic Residues in the C-Terminal Domain of the Marburg Virus Matrix Protein VP40 Disrupts Trafficking to the Plasma Membrane.
    Wijesinghe KJ; McVeigh L; Husby ML; Bhattarai N; Ma J; Gerstman BS; Chapagain PP; Stahelin RV
    Viruses; 2020 Apr; 12(4):. PubMed ID: 32344654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Roles of YIGL sequence of Ebola virus VP40 on genome replication and particle production.
    Urata S; Ishikawa T; Yasuda J
    J Gen Virol; 2019 Jul; 100(7):1099-1111. PubMed ID: 31184566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Membrane association and localization dynamics of the Ebola virus matrix protein VP40.
    Gc JB; Gerstman BS; Chapagain PP
    Biochim Biophys Acta Biomembr; 2017 Oct; 1859(10):2012-2020. PubMed ID: 28711356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of Exosomal VP40 in Ebola Virus Disease.
    Pleet ML; DeMarino C; Lepene B; Aman MJ; Kashanchi F
    DNA Cell Biol; 2017 Apr; 36(4):243-248. PubMed ID: 28177658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PI(4,5)P
    Johnson KA; Budicini MR; Bhattarai N; Sharma T; Urata S; Gerstman BS; Chapagain PP; Li S; Stahelin RV
    J Lipid Res; 2024 Mar; 65(3):100512. PubMed ID: 38295986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.